Evidence map›Paper›PMID 40650968›Full record

ArticleNucleic acids research2025

A-to-I mRNA editing recodes hundreds of genes in dozens of species and produces endogenous protein isoforms in bacteria.

Eyal Elias, Isaac Gifford, Liron Didi, Ofir Fargeon, Danielle Arad, Rinat Cohen-Pavon, Gil Sorek, Liron Levin, Dganit Melamed, Liam Aspit and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Compendium of RNA modifications for bacterial stress adaptation.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Eyal EliasThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0009-0002-8959-1347
Isaac GiffordDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78751, United States.
Liron DidiThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0009-0002-8731-0978
Ofir FargeonThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0009-0008-7419-5281
Danielle AradThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0009-0001-8505-4424
Rinat Cohen-PavonThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Gil SorekDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Liron LevinBioinformatics Core Facility, llse Katz Institute for Nanoscale Science and Technology, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.ORCID 0009-0003-1591-7903
Dganit MelamedThe Smoler Protein Research Center, Technion Israel Institute of Technology, Haifa 3200003, Israel.
Liam AspitThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0000-0001-7539-8525
Jeffrey E BarrickDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78751, United States.ORCID 0000-0003-0888-7358
Dan Bar-YaacovThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0000-0002-0599-5153

Funding

College of Natural SciencesEuropean Research CouncilEuropean Research Council 101116636Israel Science Foundation 376/2023U.S. National Science Foundation MCB-2123996
6 · The paper itself

Abstract

Adenosine-to-inosine (A-to-I) messenger RNA (mRNA) editing can affect the sequence and function of translated proteins and has been extensively investigated in eukaryotes. However, the prevalence of A-to-I mRNA editing in bacteria, its governing regulatory principles, and its biological significance are poorly understood. Here, we show that A-to-I mRNA editing occurs in hundreds of transcripts across dozens of gammaproteobacterial species, with most edits predicted to recode protein sequences. Furthermore, we reveal conserved regulatory determinants controlling editing across gammaproteobacterial species. Using Acinetobacter baylyi as a model, we show that mutating TadA, the mediating enzyme, reduces editing across all sites. Conversely, overexpressing TadA resulted in the editing of >300 transcripts, attesting to the editing potential of TadA. Notably, we show for the first time, at the protein level, that normal levels of A-to-I mRNA editing lead to wild-type bacteria expressing two protein isoforms from a single gene. Finally, we show that a TadA mutant with deficient editing activity does not grow at high temperatures, suggesting that RNA editing has a functional role in bacteria. Our work reveals that A-to-I mRNA editing in bacteria is widespread and has the potential to reshape the bacterial transcriptome and proteome.

Indexed as

AdenosineBacterial ProteinsGammaproteobacteriaInosineRNA EditingRNA, MessengerAcinetobacterGene Expression Regulation, BacterialMutationProtein IsoformsAdenosineBacterial ProteinsInosineProtein IsoformsRNA, Messenger

Identifiers

PMID40650968
PMCPMC12255301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.